Table 2.
Intra- and postoperative data
| Group 1 | Group 2 | p-value | ||
|---|---|---|---|---|
| Patients | N | 44 | 43 | |
| Type of LTX | ||||
| Single | N | 8 | 15 | 0.0927 |
| (%) | (18.18) | (34.88) | ||
| Bilateral | n | 36 | 28 | |
| (%) | (81.82) | (65.12) | ||
| Induced immunosuppression | n | 34 | 31 | 0.6281 |
| (%) | (77.27) | (72.09) | ||
| Cardio-circulatory shock | n | 5 | 1 | 0.2024 |
| (%) | (11.36) | (2.33) | ||
| Time (hours) on vasoactive amine therapy | Median | 64.00 | 72.00 | 0.2363 |
| (L95%CI–U95%CI) | (50.06–112.4) | (41.39–234.6) | ||
| Blood transfusions | n | 21 | 18 | 0.6681 |
| (%) | (47.73) | (41.86) | ||
| IMV > 96 ore | n | 14 | 17 | 0.5065 |
| (%) | (31.82) | (39.53) | ||
| Tracheostomy | n | 10 | 7 | 0.5902 |
| (%) | (22.73) | (16.28) | ||
| Time (hours) on NO inhalation therapy | Median | 48.00 | 48.00 | 0.4267 |
| (L95%CI–U95%CI) | (39.13–102.9) | (39.35–73.96) | ||
| Intraoperative ECMO | n | 11 | 12 | 0.8112 |
| (%) | (25.00) | (27.91) | ||
| Postoperative ECMO | n | 6 | 2 | 0.2656 |
| (%) | (13.64) | (4.65) | ||
| PGD grade at 72 h | ||||
| Grade 0 | n | 10 | 5 | 0.1198 |
| (%) | (22.73) | (11.63) | ||
| Grade 1 | n | 15 | 11 | |
| (%) | (34.09) | (25.58) | ||
| Grade 2 | n | 12 | 11 | |
| (%) | (27.27) | (25.58) | ||
| Grade 3 | n | 7 | 16 | |
| (%) | (15.91) | (37.21) | ||
| Time (days) in intensive care | Median | 9.00 | 9.00 | 0.5990 |
| (L95%CI–U95%CI) | (12.98–23.81) | (10.48–22.15) | ||
| Time (days) in hospital | Median | 36.00 | 37.00 | 0.4161 |
| (L95%CI–U95%CI) | (38.22–54.71) | (36.78–48.00) | ||
Patients were divided between those who had no episodes of CMV infection (Group 1) and those who had at least one episode (Group 2)
LTX lung transplant, IMV invasive mechanical ventilation, NO nitric oxide, ECMO extracorporeal membrane oxygenation, PGD primary graft dysfunction